Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines - Wikidata - wikimedia - TriplyDB

Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines

Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines

http://www.wikidata.org/entity/Q35049480

about

Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption Modified Nanoemulsions with Iron Oxide for Magnetic Resonance Imaging Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.Advances in pulmonary delivery of nanoparticles.Nasal-nanotechnology: revolution for efficient therapeutics delivery.The mucosal adjuvant potential of cross-linked dextran microspheres as dry powder.

P2860

Q28553915-4FC6EFE6-7B20-46F6-813A-DFD7AD86E0EC Q36320689-60BFE729-BB20-4E7D-B5F7-246EDF65F93E Q37130834-10BEACFA-72CB-496F-8558-D2E7F8146BC5 Q37320191-118BDF46-2EF0-4291-83F0-1E1C75245753 Q37627725-F5F975DD-2F0F-4D0C-BBC4-1EFBDF28AAE5 Q37909465-FCB41DEB-454B-41E8-BD5F-B75D93B37565 Q38217878-9F7F6ECB-4689-436D-AD12-9E55707549A6 Q43236610-A5787349-3C31-4263-B1DC-9D70471AE3C1

P2860

Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines

http://www.wikidata.org/entity/Q35049480

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Characterization of stability ...... th nanoemulsion-based vaccines

@ast

Characterization of stability ...... th nanoemulsion-based vaccines

@en

type

label

Characterization of stability ...... th nanoemulsion-based vaccines

@ast

Characterization of stability ...... th nanoemulsion-based vaccines

@en

prefLabel

Characterization of stability ...... th nanoemulsion-based vaccines

@ast

Characterization of stability ...... th nanoemulsion-based vaccines

@en

P1433

Q35049480-025A6164-B79C-4BB6-90EA-353394924EA6

P1476

Q35049480-6F91BBC2-37B9-4D40-9330-DCD43B0E89F0

P2093

Q35049480-4453588C-8499-4E7F-8ABA-10A250D98FE9

Q35049480-4539F148-E4C3-46B1-AEB2-06B8C41DDCA2

Q35049480-53868978-0793-440E-BC55-9DC7BB8D41C1

Q35049480-86DE7F76-120D-4DB7-A58E-449732F5FAA9

Q35049480-A56C1D2F-AB8D-4397-A60D-A98E50AA8743

Q35049480-C47F6D0E-E623-4529-898F-591A902A8E42

Q35049480-D51E1F4E-24CD-4A00-B266-9C4E8248E711

Q35049480-E228F12B-9563-4754-A0B2-943291FCA850

Q35049480-F31C74E0-990B-4153-A655-45FDA1D1299F

Q35049480-F71450A9-8B78-450A-A04E-C00615A888EF

P2860

Q35049480-096A5CD8-EEB3-47B0-9B76-7BE19E22122F

Q35049480-119AB97F-C676-435B-8D43-EBC6AEC5489E

Q35049480-1566CAAE-B4A6-40A9-8453-6D6E878A874E

Q35049480-26242299-1DFC-453A-BF42-2101472A291A

Q35049480-31277CEC-C6D6-4F52-9686-7221B992E284

Q35049480-31D9F0F4-F7C3-41E9-AE66-1A3098C3E91F

Q35049480-3AE2D8BC-4DB1-4B6D-9194-98D2C1EDE728

Q35049480-4A55E2F3-ED28-4544-85AC-ACA4DE925BFA

Q35049480-52A07243-ED2F-4A9E-AEF2-E8580FB85446

Q35049480-55A89B77-348A-4DD3-803A-E7D7D410D2C1

P304

Q35049480-1A51C62E-FD38-475A-9FBF-F7A7C147C2A6

P31

Q35049480-1DC6907E-F808-47C2-84C6-1C1D718B3188

P356

Q35049480-FF5FBA18-55B8-42E7-ABCE-9D4F4BBC1BCE

P433

Q35049480-C7304F4B-0A09-4B5F-96DA-E397755B0D35

P478

Q35049480-DA21E4D3-ED85-467A-86DD-FF99E661207B

P577

Q35049480-766D526D-0992-4F0E-99B2-BF78DD1177C7

P5875

Q35049480-FD271C48-0341-4D63-8523-92BCB02A3C48

P698

Q35049480-4942010A-71A2-45F7-93A6-1131C08706B4

P932

Q35049480-B54F9A23-9818-4FA5-8CBF-35A14A18460A

P356

P1433

Journal of Aerosol Medicine and Pulmonary Drug Delivery

P1476

Characterization of stability ...... th nanoemulsion-based vaccines

@en

P2093

Abhishek M Shetty

http://www.w3.org/2001/XMLSchema#string

Andrzej Myc

http://www.w3.org/2001/XMLSchema#string

Anna U Bielinska

http://www.w3.org/2001/XMLSchema#string

James R Baker

http://www.w3.org/2001/XMLSchema#string

Jessica Knowlton

http://www.w3.org/2001/XMLSchema#string

Julie Suman

http://www.w3.org/2001/XMLSchema#string

Nicholas Mank

http://www.w3.org/2001/XMLSchema#string

Paul E Makidon

http://www.w3.org/2001/XMLSchema#string

Shraddha S Nigavekar

http://www.w3.org/2001/XMLSchema#string

Trent Rook

http://www.w3.org/2001/XMLSchema#string

P2860

The influence of spray properties on intranasal deposition

Lymphotactin acts as an innate mucosal adjuvant

Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway.

Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

Towards the rational design of Th1 adjuvants.

Nasal drug delivery--possibilities, problems and solutions.

Prospects for human mucosal vaccines.

P304

77-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JAMP.2009.0766

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26835305

http://www.w3.org/2001/XMLSchema#string

P698

19778268

http://www.w3.org/2001/XMLSchema#string

P932

3116510

http://www.w3.org/2001/XMLSchema#string